Group 1 - Kanghong Pharmaceutical received a drug registration certificate for Lifisig Eye Drops, approved for treating dry eye symptoms [1] - Kanghong Biotech, a wholly-owned subsidiary, received clinical trial approval for KH813 injection for metastatic non-squamous non-small cell lung cancer [1] - Kanghong Pharmaceutical was established in October 1996, focusing on drug and medical device research, production, and sales [1] Group 2 - Guoyuyuan's subsidiary received a government subsidy of 7.5521 million yuan, accounting for 10.14% of the company's audited net profit for 2024 [2] - Guoyuyuan was founded in November 1996, specializing in drug research, production, and sales [3] Group 3 - Haicheng Bonda's subsidiary signed a lease termination agreement, incurring a termination fee of 3.35 million USD [4] - Haicheng Bonda was established in December 2009, providing comprehensive modern logistics services [4] Group 4 - Hongxin Electronics' subsidiary signed contracts totaling 373 million yuan for computing power business [5] - Hongxin Electronics was founded in September 2003, focusing on FPC research, design, manufacturing, and sales [6] Group 5 - Tianbang Food reached a settlement agreement regarding a 1.214 billion yuan lawsuit, agreeing to repay 410 million yuan over 36 months [8] - Tianbang Food was established in September 1996, specializing in pig farming and pork processing [9] Group 6 - Daoshi Technology's controlling shareholder plans to reduce holdings by up to 1.97% of the company's shares [10] - Daoshi Technology was founded in September 2007, focusing on ceramic color glazes and related products [10] Group 7 - Jinpu Titanium is planning a major asset restructuring, leading to a stock suspension [10] - Jinpu Titanium was established in November 1989, specializing in titanium dioxide production and sales [11] Group 8 - Shenzhen Energy plans to invest 6.332 billion yuan in upgrading the Mawan Power Plant [12] - Shenzhen Energy was founded in August 1993, focusing on conventional and renewable energy development [13] Group 9 - Lihua Co. plans to reduce holdings by up to 3% of the company's shares [14] - Lihua Co. was established in June 1997, specializing in the breeding and sales of poultry [15] Group 10 - China Communications Construction Company plans to repurchase shares worth 500 million to 1 billion yuan [16] - China Communications Construction Company was founded in October 2006, focusing on infrastructure design and construction [17] Group 11 - Huatiankeji's subsidiary received a government subsidy of 80.6569 million yuan, accounting for 13.09% of the company's latest audited net profit [20] - Huatiankeji was established in December 2003, specializing in integrated circuit packaging and testing [21] Group 12 - Luxin Chuangtou plans to acquire shares in Hongke Electronics for a total of 9 million yuan [23] - Luxin Chuangtou was founded in November 1993, focusing on venture capital and industrial development [24] Group 13 - Feilong Co.'s controlling shareholder plans to reduce holdings by up to 563,250 shares [25] - Feilong Co. was established in January 2001, specializing in thermal management components for automotive and civil applications [26] Group 14 - Linglong Tire submitted an application for H-share listing on the Hong Kong Stock Exchange [27] - Linglong Tire was founded in June 1994, focusing on tire design, development, manufacturing, and sales [27] Group 15 - Saiwei Electronics plans to acquire 9.5% of its subsidiary's shares for up to 324 million yuan [28] - Saiwei Electronics was established in May 2008, focusing on MEMS chip development and semiconductor equipment [28] Group 16 - Suzhou Bank's major shareholder plans to increase holdings by no less than 400 million yuan [29] - Suzhou Bank was founded in December 2004, focusing on various banking services [29]

Company Announcements - Jihua Group's existing product system does not involve brain-computer interface related fields [1] - Prit's plan to invest 1 billion yuan to build a plastic modification materials headquarters and R&D manufacturing base in South China [1][2] - Lian De Equipment won a contract worth 157 million yuan for BOE's 8.6 generation AMOLED production line project [1][2] - Jiadu Technology plans to issue shares (H-shares) overseas and list on the Hong Kong Stock Exchange [1][2] - Longdi Group intends to acquire no more than 20.1667% equity in Jujia Technology [1][4] - New Zhonggang plans to repurchase shares worth 40 million to 80 million yuan [1][4] - Xiaogoods City expects a net profit increase of 12.57% to 17.40% in the first half of the year [1][4] - Sinopec Capital plans to reduce its holdings by no more than 3.5256 million shares in Haizheng Materials through block trading [1][4] - Lihua Co., Ltd. intends to reduce its holdings by no more than 3.00% [1][4] - Zhimin Da plans to raise no more than 213 million yuan through a private placement [1][5] - Xiangtong Co. plans to issue corporate bonds not exceeding 4 billion yuan [1][5] Performance Forecasts - Hanyu Pharmaceutical expects a half-year profit of 142 million to 162 million yuan, turning a profit compared to the previous year [4] - Taotao Automotive anticipates a net profit increase of 70.34% to 97.81% in the first half of the year [4] - Weichai Heavy Machinery expects a net profit increase of 40% to 60% in the first half of the year [4] Shareholding Changes - Lihua Co., Ltd.'s actual controller Cheng Lili and his concerted actors plan to reduce their holdings by no more than 3.00% [4] - He Shi Eye Hospital's Advanced Manufacturing Fund plans to reduce its holdings by no more than 2% [4] - Haitan Ruisheng's shareholder He Lin and his concerted actors plan to reduce their holdings by no more than 2.9463% [4] - Sinopec Capital plans to reduce its holdings by no more than 3.5256 million shares in Haizheng Materials [4] Other Announcements - Zhimin Da plans to raise no more than 213 million yuan through a private placement [5] - Yuyuan Co. plans to issue corporate bonds not exceeding 40 billion yuan [5] - Jinhongshun has terminated the planning of a major asset restructuring [5]

Company Highlights - Hanyu Pharmaceutical expects a net profit of 142 million to 162 million yuan for the first half of 2025, benefiting from increased global market demand and successful product approvals [1] - Taotao Automotive anticipates a net profit growth of 70% to 98% year-on-year for the first half of 2025, driven by enhanced brand influence and improved operational efficiency [2] - Xiaogoods City projects a net profit increase of 13% to 17% for the first half of 2025, attributed to growth in main business revenue and trade fulfillment services [2] - Hongxin Electronics signed contracts totaling 373 million yuan for computing power services through its subsidiaries [3] - Alloy Investment's controlling shareholder will change to Jiuzhou Hengchang, leading to the resumption of trading [3] - Hangzhou High-tech is planning a change in control, with a suspension of trading expected for no more than two trading days [4] - Junpu Intelligent signed a sales framework contract for humanoid robots worth 28.25 million yuan [7] - Lens Technology plans to issue 262 million H-shares globally, with an initial price range set between 17.38 and 18.18 HKD [8] - Saintno Biopharmaceuticals received a drug registration certificate for its product, further enhancing its market competitiveness [12] Investment & Contracts - Shenzhen Energy plans to invest 6.332 billion yuan in upgrading the Mawan Power Plant, aligning with national energy policies [17] - China Railway Construction won a contract worth 3.781 billion yuan for the China-Kyrgyzstan-Uzbekistan railway project [27] - China Railway secured contracts totaling approximately 5.343 billion yuan for the same railway project [28] - Zhongtian Technology's subsidiary won multiple marine energy project contracts totaling about 1.722 billion yuan [29] - Lande Group intends to acquire a 20.1667% stake in Jujia Technology for up to 121 million yuan, enhancing its capabilities in high-performance materials [21][22] Financing & Capital Increase - Yiwei Lithium Energy submitted an application for H-share issuance and listing in Hong Kong [30] - Jiadou Technology plans to issue H-shares and list on the Hong Kong Stock Exchange [30] - Helin Micro-Nano is preparing to issue H-shares for listing in Hong Kong [30] Other Developments - Renfu Pharmaceutical received approval for its midazolam injection in France, with expected annual sales of approximately 33 million USD [31] - Kanghong Pharmaceutical obtained a drug registration certificate for its eye drop product, enhancing its product pipeline in the ophthalmology sector [32]

证券代码：000027 证券简称：深圳能源 公告编号：2025-020 | 公司债券代码：149676 | 公司债券简称：21 深能 | 01 | | --- | --- | --- | | 公司债券代码：149677 | 公司债券简称：21 深能 | 02 | | 公司债券代码：149927 | 公司债券简称：22 深能 | 02 | | 公司债券代码：149983 | 公司债券简称：22 深能 | Y1 | | 公司债券代码：149984 | 公司债券简称：22 深能 | Y2 | | 公司债券代码：148628 | 公司债券简称：24 深能 | Y1 | | 公司债券代码：148687 | 公司债券简称：24 深能 | 01 | | 公司债券代码：524032 | 公司债券简称：24 深能 | Y2 | 深圳能源集团股份有限公司 关于投资建设妈湾电厂升级改造煤电环保替代 一期工程项目的公告 公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记 载、误导性陈述或重大遗漏。 统一社会信用代码：914403006188167068。 法定代表人：邵建平。 企业类型：有限责任公司（中外合资）。 注 ...

二、董事会会议审议情况 证券代码：000027 证券简称：深圳能源 公告编号：2025-019 | 公司债券代码：149676 | 公司债券简称：21 深能 | 01 | | --- | --- | --- | | 公司债券代码：149677 | 公司债券简称：21 深能 | 02 | | 公司债券代码：149927 | 公司债券简称：22 深能 | 02 | | 公司债券代码：149983 | 公司债券简称：22 深能 | Y1 | | 公司债券代码：149984 | 公司债券简称：22 深能 | Y2 | | 公司债券代码：148628 | 公司债券简称：24 深能 | Y1 | | 公司债券代码：148687 | 公司债券简称：24 深能 | 01 | | 公司债券代码：524032 | 公司债券简称：24 深能 | Y2 | 深圳能源集团股份有限公司 董事会八届三十五次会议决议公告 公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记 载、误导性陈述或重大遗漏。 一、董事会会议召开情况 深圳能源集团股份有限公司（以下简称：公司）董事会八届三十五次会议通 知及相关文件已于 2025 年 6 ...

Core Viewpoint - Shenzhen Energy's subsidiary plans to invest 6.332 billion yuan in the upgrade and transformation of the Mawan Power Plant, aligning with national policies and regional power demands [1] Investment Details - The project will have an installed capacity of 2×660 megawatts [1] - Total investment for the project is 6.332 billion yuan, with 1.305 billion yuan funded from the company's own resources [1] - The remaining investment will be secured through financing [1] Strategic Importance - The project aims to meet the regional electricity load development needs and alleviate power supply pressure in western Shenzhen [1] - It aligns with the national "three reforms and one linkage" policy, supporting the construction of a new power system in the Guangdong-Hong Kong-Macao Greater Bay Area [1]

Core Viewpoint - Shenzhen Energy (000027) announced that its subsidiary, Shenzhen Mawan Power Co., Ltd., plans to invest 6.332 billion yuan in the upgrade and transformation of the Mawan Power Plant, focusing on coal power environmental alternatives for the first phase of the project [1] Investment Details - The project will have an installed capacity of 2×660 megawatts [1] - Out of the total investment, 1.304 billion yuan will be self-raised by Mawan Company, while the remaining funds are intended to be secured through financing [1] Strategic Alignment - The project aligns with the company's strategic development direction and aims to meet the regional electricity load growth needs [1] - It is designed to alleviate the power supply pressure in the western part of Shenzhen and complies with the national "three reforms linkage" policy [1] Risks Identified - The project faces risks related to fuel prices, electricity prices not meeting expectations, and tight construction schedules [1]

受托管理事务报告 （2024 年度） 深圳能源集团股份有限公司 （住所：广东省深圳市福田区福田街道金田路 2026 号能源大厦北塔 楼 9 层，29-31 层，34-41 层） 深圳能源集团股份有限公司公司债券 债券受托管理人 （住所：北京市朝阳区建国门外大街 1 号国贸大厦 2 座 27 层及 28 层） 二〇二五年六月 重要声明 本报告依据《公司债券发行与交易管理办法》（以下简称《管理办法》）、 《公司债券受托管理人执业行为准则》（以下简称《执业行为准则》）、证券交 易所公司债券上市规则（以下简称"上市规则"）、发行人与中国国际金融股份 有限公司（以下简称"中金公司"或"受托管理人"）签订的债券受托管理协议 （以下简称"受托管理协议"）及其它相关信息披露文件以及深圳能源集团股份 有限公司（以下简称"发行人"或"公司"）出具的相关说明文件和提供的相关 资料等，由受托管理人中金公司编制。中金公司编制本报告的内容及信息均来源 于深圳能源集团股份有限公司提供的资料或说明。 本报告不构成对投资者进行或不进行某项行为的推荐意见，投资者应对相关 事宜作出独立判断，而不应将本报告中的任何内容据以作为中金公司所作的承诺 或 ...

2019 年第二期深圳能源集团股份有限公司绿色债券 2024 年度 债权代理事务报告并发行人履约情况及偿债能力分析报告 深圳能源集团股份有限公司公司债券全体持有人： 国泰海通证券股份有限公司（以下简称国泰海通证券或本公司）作为 2019 年第二期深圳能源集团股份有限公司绿色债券（以下简称 19 深圳能源绿色债 02、19 深能 G2）的牵头主承销商及债权代理人，按照相关要求出具本报告。 为出具本报告，本公司与深圳能源集团股份有限公司（以下简称发行人） 进行接洽，对于出具本报告有关的事务进行了必要的调查。本报告依据本公司 对有关情况的调查、发行人出具的证明文件进行判断，对上述债券存续期间所 了解的信息进行披露。在本报告中对有关审计报告等专业数据及事项的引述， 不表明本公司对这些报告、数据的真实性和准确性作出任何明示或默示的保证。 债券简称：19 深圳能源绿色债 02 债券代码：1980199.IB 债券简称：19 深能 G2 债券代码：111084.SZ 本公司未对上述债券的投资价值做出任何评价，也未对上述债券的投资风 险做出任何判断。上述债券的投资者应自行判断和承担投资风险。 一、发行人的基本情况 | 发行人 ...

债券简称：19 深圳能源绿色债 01 债券代码：1980049.IB 债券简称：19 深能 G1 债券代码：111077.SZ 2019 年第一期深圳能源集团股份有限公司绿色债券 2024 年度 债权代理事务报告并发行人履约情况及偿债能力分析报告 深圳能源集团股份有限公司公司债券全体持有人： 国泰海通证券股份有限公司（以下简称国泰海通证券或本公司）作为 2019 年第一期深圳能源集团股份有限公司绿色债券（以下简称 19 深圳能源绿色债 01、19 深能 G1）的牵头主承销商及债权代理人，按照相关要求出具本报告。 为出具本报告，本公司与深圳能源集团股份有限公司（以下简称发行人） 进行接洽，对于出具本报告有关的事务进行了必要的调查。本报告依据本公司 对有关情况的调查、发行人出具的证明文件进行判断，对上述债券存续期间所 了解的信息进行披露。在本报告中对有关审计报告等专业数据及事项的引述， 不表明本公司对这些报告、数据的真实性和准确性作出任何明示或默示的保证。 本公司未对上述债券的投资价值做出任何评价，也未对上述债券的投资风 险做出任何判断。上述债券的投资者应自行判断和承担投资风险。 一、发行人的基本情况 | 发行人 ...